# FDA Inspection 816296 - UPMC Horizon - Greenville - January 30, 2013

Source: https://www.keypedia.com/records/fda_inspections/upmc-horizon-greenville/d652ed6d-49ba-4d06-9fdc-1067b06e08e5
Source feed: FDA_Inspections

> FDA Inspection 816296 for UPMC Horizon - Greenville on January 30, 2013. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 816296
- Company Name: UPMC Horizon - Greenville
- Inspection Date: 2013-01-30
- Classification: No Action Indicated (NAI)
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 707046 - 2011-01-31](https://www.keypedia.com/records/fda_inspections/upmc-horizon-greenville/80d1a4b8-26c2-4faf-a29f-8fb2d554550f)
- [FDA Inspection 599816 - 2009-07-30](https://www.keypedia.com/records/fda_inspections/upmc-horizon-greenville/c1814358-847d-4a2b-a4d3-7875d01ace1d)

Company: https://www.keypedia.com/companies/upmc-horizon-greenville/dfaf18c7-f4e5-4822-9335-84670a5b633c

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d